Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

2 terminated/withdrawn out of 8 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1

5(62.5%)

Phase 2

3(37.5%)

8Total

Early Phase 1(5)

Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT05396781Phase 2Completed

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening

Role: lead

NCT02029937Phase 2Unknown

High Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia

Role: lead

NCT02018367Phase 2Unknown

Accuracy, Yield and Clinical Impact of a Low-Cost HRME in the Early Diagnosis of Esophageal Adenocarcinoma

Role: lead

NCT01384227Early Phase 1Completed

Evaluation of a Miniaturized Microscope Device for the Detection of Barrett's Neoplasia: A Pilot Study

Role: lead

NCT01384240Early Phase 1Terminated

Evaluation of a Low-Cost High Resolution Microendoscope for the Detection of Lower Gastrointestinal Neoplasia

Role: lead

NCT01384695Early Phase 1Terminated

A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1

Role: lead

NCT01384708Early Phase 1Completed

Evaluation of a Miniaturized Microscope Device for the Detection of Esophageal Squamous Cell Cancer

Role: lead

NCT01384864Early Phase 1Completed

Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia

Role: lead

All 8 trials loaded